ArticleBMC medical genomics2019

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.

Miguel Nava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.